These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M, van Graafeiland BJ, Monetti N, Bombardieri E. Eur J Nucl Med; 1998 Oct; 25(10):1396-403. PubMed ID: 9818279 [Abstract] [Full Text] [Related]
7. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours. Schillaci O, Corleto VD, Annibale B, Scopinaro F, Delle Fave G. Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127 [Abstract] [Full Text] [Related]
17. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors. Kisker O, Bartsch D, Weinel RJ, Joseph K, Welcke UH, Zaraca F, Rothmund M. J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069 [Abstract] [Full Text] [Related]
18. Limited role of carbidopa-assisted 18F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms. Imperiale A, Averous G, Helali M, Taieb D, Pessaux P, Goichot B, Addeo P, Bachellier P. Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959 [Abstract] [Full Text] [Related]
19. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Kann PH, Balakina E, Ivan D, Bartsch DK, Meyer S, Klose KJ, Behr T, Langer P. Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764 [Abstract] [Full Text] [Related]